Anti-KLK12/ KLK-L5/ KLKL5 functional antibody

Anti-KLK12/ KLK-L5/ KLKL5 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KLK12/KLK12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1049-Ab-1/ GM-Tg-hg-SE1049-Ab-2Anti-Human KLK12 monoclonal antibodyHuman
GM-Tg-rg-SE1049-Ab-1/ GM-Tg-rg-SE1049-Ab-2Anti-Rat KLK12 monoclonal antibodyRat
GM-Tg-mg-SE1049-Ab-1/ GM-Tg-mg-SE1049-Ab-2Anti-Mouse KLK12 monoclonal antibodyMouse
GM-Tg-cynog-SE1049-Ab-1/ GM-Tg-cynog-SE1049-Ab-2Anti-Cynomolgus/ Rhesus macaque KLK12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1049-Ab-1/ GM-Tg-felg-SE1049-Ab-2Anti-Feline KLK12 monoclonal antibodyFeline
GM-Tg-cang-SE1049-Ab-1/ GM-Tg-cang-SE1049-Ab-2Anti-Canine KLK12 monoclonal antibodyCanine
GM-Tg-bovg-SE1049-Ab-1/ GM-Tg-bovg-SE1049-Ab-2Anti-Bovine KLK12 monoclonal antibodyBovine
GM-Tg-equg-SE1049-Ab-1/ GM-Tg-equg-SE1049-Ab-2Anti-Equine KLK12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1049-Ab-1/ GM-Tg-hg-SE1049-Ab-2; GM-Tg-rg-SE1049-Ab-1/ GM-Tg-rg-SE1049-Ab-2;
GM-Tg-mg-SE1049-Ab-1/ GM-Tg-mg-SE1049-Ab-2; GM-Tg-cynog-SE1049-Ab-1/ GM-Tg-cynog-SE1049-Ab-2;
GM-Tg-felg-SE1049-Ab-1/ GM-Tg-felg-SE1049-Ab-2; GM-Tg-cang-SE1049-Ab-1/ GM-Tg-cang-SE1049-Ab-2;
GM-Tg-bovg-SE1049-Ab-1/ GM-Tg-bovg-SE1049-Ab-2; GM-Tg-equg-SE1049-Ab-1/ GM-Tg-equg-SE1049-Ab-2
Products NameAnti-KLK12 monoclonal antibody
Formatmab
Target NameKLK12
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KLK12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1049-Ag-1Recombinant multi-species KLK12/ KLK-L5/ KLKL5 protein


    Target information

    Target IDGM-SE1049
    Target NameKLK12
    Gene ID43849,69511,308564,719517,611766,101097440,618448,100067108
    Gene Symbol and Synonyms2310008B01Rik,KLK-L5,KLK12,KLKL5,Klnk
    Uniprot AccessionQ9UKR0
    Uniprot Entry NameKLK12_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000186474
    Target ClassificationN/A

    The target: KLK12, gene name: KLK12, also named as KLK-L5, KLKL5. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Alternate splicing of this gene results in three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.